Actively Recruiting
Percutaneous Peritoneal Dialysis Catheter Insertion (PREDICT)
Led by Universitair Ziekenhuis Brussel · Updated on 2023-10-04
500
Participants Needed
2
Research Sites
208 weeks
Total Duration
On this page
Sponsors
U
Universitair Ziekenhuis Brussel
Lead Sponsor
U
UMC Utrecht
Collaborating Sponsor
AI-Summary
What this Trial Is About
Peritoneal dialysis (PD) is the most frequent modality of home dialysis for patients with kidney failure. Most PD catheters are placed using a laparoscopic technique. This approach requires the availability of a qualified surgeon, time in the operating theater and general anaesthesia for the patient. Thus, the laparoscopic technique is less suitable for patients with severe heart failure or multimorbidity where general anaesthesia is not possible. PD catheters can also be inserted using a percutaneous strategy using a modified Seldinger technique. This strategy can be performed bedside under local anaesthesia, by the nephrologist, radiologist, a surgeon, physician assistant or qualified nurse. The availability of the percutaneous implantation strategy of a PD catheter in a nephrology center may accomodate more patients to receive a PD catheter insertion, including those who have a contraindication to general anaesthesia or need urgent PD. The PREDICT project aims to increase knowledge and competencies on percutaneous PD catheter insertions by training centers for this technique. By establisching a prospective registry, the outcomes of percutaneously inserted PD catheters, both in experienced and newly trained centers, will be assessed.
CONDITIONS
Official Title
Percutaneous Peritoneal Dialysis Catheter Insertion (PREDICT)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18 years
- Percutaneous peritoneal dialysis catheter insertion performed between March 1, 2023, and March 1, 2026
- Patients can be included from 4 weeks before up to 12 weeks after PD catheter insertion
You will not qualify if you...
- Unable to provide informed consent
- Life expectancy less than 3 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Universitair Ziekenhuis Brussel
Brussels, Belgium, 1090
Actively Recruiting
2
UMC Utrecht
Utrecht, Netherlands
Actively Recruiting
Research Team
K
Karlien François, MD PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here